| JANUARY 2009 |
|
 | |
|
|
NYC Bioscience Bulletin provides the latest news on the thriving bioscience cluster in New York City. Visit www.nycbiotech.com for more information on how NYCEDC can assist your business. | | |
|
|
|
|
|
|
|
Medical Breakthrough Ranked Number One by Time Magazine |
|
A milestone experiment performed by researchers at Harvard and NYC's Columbia University is the first to demonstrate that disease specific stem cells may be derived from an individual patient. The breakthrough, supported by NYC-based Project ALS and New York Stem Cell Foundation, opens the possibility of modeling a patient's specific disease outside of the patient, to improve investigation and drug screening, and to potentially develop new neurons to replace the damaged ones in the patient. |
| |
|
Obama Selects Harold Varmus as Science Advisor |
|
Harold E. Varmus, a Nobel Prize winner for his research on the genetic basis of cancer, was recently named co-chairman for the President's Council of Advisors on Science and Technology by President-elect Barack Obama. Varmus formerly served as Director of the National Health Institute under the Clinton Administration and currently serves as President of the Memorial Sloan-Kettering Cancer Center in NYC. |
| |
|
Antigenics Seeking Approval for First Cancer Vaccine |
|
Antigenics, a biotech company working to develop treatments for cancers and infectious diseases, requested marketing approval from the European Medicines Agency (EMEA) for Oncophage for the treatment of earlier-stage, localized renal cell carcinoma (kidney cancer). If approved, Oncophage will be the first therapeutic cancer vaccine to receive a marketing license from the European agency. |
| |
|
|
|
Innovation of the Year Awarded to NYC Company |
|
New Wave Surgical Corporation's latest product, D-HELP, for multidisciplinary application in minimally invasive surgery, was chosen by the Society of Laparoendoscopic Surgeons as the most innovative product of 2008. New Wave Surgical designs, patents and markets medical devices for the laparoscopic and endoscopic surgical markets. |
| |
|
Stem Cell Summit Coming to NYC |
|
The 4th Annual Stem Cell Summit, the largest gathering of stem cell technology companies and entrepreneurs, will convene in lower Manhattan on February 17th and will showcase investment opportunities in the stem cell marketplace, groundbreaking stem cell products, and more. NYCEDC will again be a sponsor of the Summit which features more than 30 presenters and a scientific panel discussion. Visit our booth or contact Lenzie Harcum if you interested in arranging a meeting. | |
|
| |
|
|
 |
|
ARMGO Pharma, Inc. |
ARMGO Pharma, Inc. is a privately held NYC-based biopharmaceutical company dedicated to applying groundbreaking, targeted research to the development of novel small-molecule therapeutics for treating debilitating cardiac, muscular and neurological disorders. ARMGO has obtained an exclusive, worldwide license from Columbia University for the innovative ryanodine receptor technology discovered by the company's scientific founder, Dr. Andrew R. Marks. |
|
| Back to Top^ | | |
|
|
|
|
|
|
|
|
| LAB LEASING OPPORTUNITIES | |
|
|
|
|
 |
For more information on the latest Bioscience activities in New York City and how NYCEDC can assist your business, visit us at www.nycbiotech.com or contact Lenzie Harcum at 212-312-3806. | | | |
|